Skip to main content
TipRanks
Go Ultimate75% OFF

Edward Frykman Insider Profile

4 Followers

Edward Frykman, Director at Arrowhead Pharmaceuticals, holds 148.85K shares in Arrowhead Pharmaceuticals (Ticker: ARWR), holds 73.29K shares in Acacia Research (Ticker: ACTG).

Edward Frykman's Trading History

ARWR
Arrowhead Pharmaceuticals
Jan 03, 2018DirectorUninformative Buy―$7.11M
ACTG
Acacia Research
Jan 06, 2015DirectorUninformative Buy―$304.89K

You May Also Like

Edward Frykman insider profile FAQ

What is the percentage of profitable transactions made by Edward Frykman?
The percentage of profitable transactions made by Edward Frykman is 0%.
What is the average return per transaction made by Edward Frykman?
The average return per transaction made by Edward Frykman is -22.40%.
What stocks does Edward Frykman hold?
Edward Frykman holds: ARWR, ACTG stocks.
What was Edward Frykman's most profitable transaction?
Edward Frykman’s most profitable transaction was an Informative Sell of ACTG stock on December 9, 2010. The return on the trade was -14.60%.
What is Edward Frykman's role in Arrowhead Pharmaceuticals?
Edward Frykman's role in Arrowhead Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.